HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

UNILEVER CUTTING COSTS BY $360 MIL ANNUALLY UNDER RESTRUCTURING

This article was originally published in The Rose Sheet

Executive Summary

UNILEVER CUTTING COSTS BY $360 MIL ANNUALLY UNDER RESTRUCTURING program targeting the company's European and North American businesses. The program, which is expected to be complete within three years, will affect 60 projects in 20 countries. In Europe, almost all of the firm's business categories will be affected, while in North America, the reorganization will focus on detergent operations in the U.S. Under the restructuring program, Unilever expects to eliminate 7,500 jobs, some of which have been announced previously. Unilever noted that "efforts will be made to achieve this job reduction through attrition, retirement and relocation."

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS000197

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel